[LDL-apheresis in the treatment familial hypercholesterolemia]

Vnitrni Lekarstvi
|January 21, 2015
PubMed

Insights

LDL-apheresis removes LDL-cholesterol via extracorporeal techniques. Studies show beneficial cardiovascular effects in severe hypercholesterolemia, despite ongoing debates on specific indications.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biochemistry

Background:

  • Familial hypercholesterolemia (FH) and elevated lipoprotein(a) are significant cardiovascular risk factors.
  • Standard pharmacotherapy may be insufficient for certain severe hypercholesterolemia cases.
  • LDL-apheresis offers a targeted extracorporeal approach to cholesterol reduction.

Purpose of the Study:

  • To review the indications and efficacy of LDL-apheresis.
  • To highlight the cardiovascular benefits of LDL-apheresis in severe hypercholesterolemia.
  • To discuss the current landscape of LDL-apheresis techniques and their applications.

Main Methods:

  • Review of existing literature and studies on LDL-apheresis.
  • Analysis of different selective LDL-cholesterol removal methods.
  • Evaluation of clinical outcomes in patients undergoing LDL-apheresis.

Main Results:

  • Six selective LDL-cholesterol removal methods are currently available.
  • Key indications include homozygous FH, refractory heterozygous FH, and resistant lipoprotein(a) elevation.
  • Evidence suggests significant cardiovascular benefits from LDL-apheresis in severe hypercholesterolemia.

Conclusions:

  • LDL-apheresis is an effective extracorporeal therapy for specific severe hypercholesterolemia conditions.
  • While indications are debated, studies support its cardiovascular benefits.
  • Further research and standardized guidelines may refine its therapeutic role.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.8K